Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 86

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 86
---
 to pay Kadimastem a termination fee of $10,000,000 and the additional fees and expenses as set forth in the Merger Agreement. For more information please see “ The Merger Agreement — Covenants of the Parties; Conduct of Business Pending the Merger; NLS Meeting” of this proxy statement/prospectus. Conditions to the Consummation of the Merger (Page 155) The Merger Agreement contains closing conditions that are customary for a transaction of this nature, including the requirement for approval by the shareholders of each of Kadimastem and NLS. The Merger has been approved by the shareholders of Kadimastem and is pending approval by the shareholders of NLS. In addition, the Merger Agreement requires NLS to have paid off, redeemed or satisfied all of its trade and vendor payables, and all of its debts to its officers, directors and shareholders. The Merger Agreement requires NLS to have at least $600,000 in cash at the Closing and requires Kadimastem to have at least $3,500,000 in cash at the Closing, in each case subject to adjustments as set forth in the Merger Agreement. Based on the proceeds received by NLS in connection with its financing transactions undertaken after the executionofthe Merger Agreement,and in accordance with the adjustments as set forth in the Merger Agreement, Kadimastem satisfied the Investment Proceeds Adjustment and will therefore not be required to have cash at Closing. The obligations of the parties to complete the Merger are subject to various additional conditions, including the conditions set forth herein under the section entitled “ The Merger Agreement — Conditions to Closing.” Regulatory approvals (Page 147) Swiss law provides for certain rules and protections of shareholders of domestic listed companies. However, because the NLS Shares are listed exclusively on the Nasdaq, several of these rules do not apply to NLS as if it were a company listed in Switzerland. In particular, the Swiss rules under the Swiss Financial Market Infrastructure Act on disclosure of shareholdings and the tender offer rules under the Swiss Financial Market Infrastructure Act, including mandatory tender offer requirements and regulations regarding voluntary tender offers, which are typically available in relation to Swiss -listedcompanies, do not apply to NLS because it is not listed in Switzerland. In the United States, NLS must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of NLS Common Shares and the filing of this proxy statement/prospectus with the